| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 554.62M | 687.41M | 623.98M | 590.90M | 451.37M | 417.65M |
| Gross Profit | 170.77M | 207.48M | 171.73M | 180.82M | 133.61M | 128.46M |
| EBITDA | 84.03M | 97.48M | 81.94M | 86.38M | 49.36M | 39.58M |
| Net Income | 41.60M | 46.65M | 38.48M | 43.62M | 20.75M | 22.49M |
Balance Sheet | ||||||
| Total Assets | 629.04M | 571.44M | 553.21M | 550.92M | 533.24M | 370.85M |
| Cash, Cash Equivalents and Short-Term Investments | 22.50M | 26.71M | 45.59M | 31.45M | 25.64M | 38.03M |
| Total Debt | 194.33M | 103.24M | 108.75M | 121.98M | 159.40M | 0.00 |
| Total Liabilities | 427.39M | 359.37M | 341.11M | 339.76M | 335.49M | 174.37M |
| Stockholders Equity | 201.66M | 212.07M | 212.10M | 211.15M | 197.75M | 196.47M |
Cash Flow | ||||||
| Free Cash Flow | -40.41M | 33.11M | 57.71M | 21.31M | 11.14M | 20.74M |
| Operating Cash Flow | -37.59M | 49.73M | 60.07M | 25.12M | 27.83M | 36.19M |
| Investing Cash Flow | -2.81M | -18.12M | -2.94M | -18.16M | -16.69M | -15.45M |
| Financing Cash Flow | 34.89M | -48.86M | -44.48M | -38.95M | -23.82M | -35.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $1.24B | 22.64 | 27.83% | 1.06% | 8.69% | 34.58% | |
75 Outperform | $5.17B | 21.28 | 13.30% | ― | -0.95% | -10.54% | |
73 Outperform | $2.84B | 27.64 | 21.20% | ― | 12.50% | 29.40% | |
65 Neutral | $1.49B | 15.20 | 9.88% | 0.70% | -3.81% | -7.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | $151.93M | -0.80 | -61.44% | 9.23% | -10.83% | -1669.11% | |
42 Neutral | $144.65M | ― | ― | ― | -8.73% | -1168.15% |
The recent earnings call for CRA International reflected a positive sentiment, with the company showcasing strong performance in both revenue and profitability. Notably, there was significant growth in international operations, particularly in the Antitrust & Competition Economics and Energy sectors. However, the company also faced challenges in managing headcount and an increase in Days Sales Outstanding (DSO), alongside a net debt position that could raise concerns. Despite these challenges, the overall highlights of the call outweighed the lowlights.
Charles River Associates (CRA) is a global consulting firm specializing in economic, financial, and management consulting services, advising clients on economic and financial matters related to litigation, regulatory proceedings, and business strategy. Headquartered in Boston, CRA operates worldwide, offering objective solutions to complex problems since 1965.
On October 30, 2025, CRA announced a 16% increase in its quarterly cash dividend to $0.57 per share, payable on December 12, 2025. The company reported strong financial results for the third quarter of 2025, with a 10.8% increase in revenue year over year to $185.9 million and a 12.7% rise in non-GAAP net income. CRA also raised its revenue guidance for the full fiscal year, reflecting confidence in its competitive position despite global economic uncertainties.
The most recent analyst rating on (CRAI) stock is a Buy with a $213.00 price target. To see the full list of analyst forecasts on Cra International stock, see the CRAI Stock Forecast page.
CRA International’s recent earnings call painted a picture of robust financial health and strategic success, with a positive sentiment prevailing despite some challenges. The company reported strong revenue growth across multiple practices, particularly in Antitrust & Competition Economics, and celebrated record-setting first-half results. These achievements led to an increase in revenue guidance, overshadowing concerns about headcount reductions, challenges in the Life Sciences practice, and high debt levels.
Charles River Associates (CRA) is a global consulting firm specializing in economic, financial, and management consulting services, providing expert advice on economic and financial matters related to litigation, regulatory proceedings, and business strategy.